Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Pharmacol Biochem Behav. 2012 Aug 27;103(2):253–259. doi: 10.1016/j.pbb.2012.08.019

Figure 4.

Figure 4

Effect of OPRD1^4 genotype on alcohol craving while on naltrexone versus placebo. Data presented are predicted values based on betas from mixed-model regression analyses. A-allele carriers showed naltrexone-induced attenuation of alcohol craving. An asterisk (* p < 0.05) indicates a significant effect of medication within a genotype group across the infusion session.